Astellas Establishes Global Patient Centricity Leadership Structure to Incorporate Patient Perspectives Across Research and Development Continuum
NORTHBROOK, Ill., Sept. 23, 2020 /PRNewswire/ -- Astellas today announced the structure and operating model for its global Patient Centricity organization designed to support the development of innovative health solutions through a deep understanding of the patient experience, medical need and behavioral drivers of care.
Under the leadership of Dr. Anthony Yanni, Senior Vice President and Global Head of Patient Centricity, the organization will be comprised of four distinct teams – Medical Intelligence and Patient Insights, Patient Insights and Solutions, the Behavioral Science Consortium and Patient Partnerships – working together to apply unique insights from patients, caregivers, healthcare providers and advocacy partners in considering how to prioritize Astellas resources to the projects with the potential to have the biggest impact on patients' lives:
"Drug development has historically focused exclusively on scientific possibility rather than integrating real-world patient insights – especially in the research space. At Astellas, we've established processes that balance 'Can We?' with 'Should We?'," said Yanni. "To be most-effective, however, integration of the patient perspective must start early in the research and discovery process and be incorporated throughout the continuum through to development and utilization. This comprehensive approach to patient-focused medicines development is what makes Astellas Patient Centricity unique, and I am thrilled with the talent we have attracted and the momentum we have established to make this vision a reality."
As part of the new structure, Yanni announced a leadership team based in the U.S. and the company's global headquarters in Japan, comprised of industry veterans with a deep commitment to innovating based on an intimate understanding of real-world patient needs:
"With these leaders, and the many colleagues around the world who have joined Patient Centricity over the past few months, we have now in place a best-in-class team dedicated to ensuring Astellas brings a conscious awareness of the patient to everything we do," said Yanni.
View original content to download multimedia:http://www.prnewswire.com/news-releases/astellas-establishes-global-patient-centricity-leadership-structure-to-incorporate-patient-perspectives-across-research-and-development-continuum-301136577.html
SOURCE Astellas Pharma Inc.